Work

Nivolumab (nivo) for patients (pts) with metastatic non-clear cell renal cell carcinoma (nccRCC): A single-institution experience.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.4585

Authors: Jad Chahoud, Matthew T. Campbell, Jianjun Gao, Amado J. Zurita, Amishi Yogesh Shah, Pavlos Msaouel, Jeremy Aaron Ross, Lianchun Xiao, Eric Jonasch, Padmanee Sharma, Nizar M. Tannir

Institutions: The University of Texas MD Anderson Cancer Center, The University of Texas Health Science Center at Houston

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891319625

Cites:

Cited by: 3

Related to: 10